Unlock Premium for Just $9.99/Month – Special Launch Offer, Limited Time Only Get Premium

MGTX MeiraGTx Holdings plc

Price (delayed)

$5.46

Market cap

$438.79M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$2.32

Enterprise value

$451.06M

MeiraGTx is a vertically integrated, clinical stage gene therapy company with six programs in clinical development and a broad pipeline of preclinical and research programs. MeiraGTx has core capabilities in ...

Highlights
MeiraGTx Holdings's debt has decreased by 8% YoY and by 4.6% QoQ
The revenue has increased by 3.7% QoQ
The company's net income has shrunk by 126% YoY and by 13% QoQ
MGTX's EPS has dropped by 98% year-on-year and by 9% since the previous quarter

Key stats

What are the main financial stats of MGTX
Market
Shares outstanding
80.37M
Market cap
$438.79M
Enterprise value
$451.06M
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
13.01
Price to sales (P/S)
12.5
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
13.07
Earnings
Revenue
$34.51M
Gross profit
$9.34M
Operating income
-$159.04M
Net income
-$167.33M
EBIT
-$154.27M
EBITDA
-$141.63M
Free cash flow
-$110.15M
Per share
EPS
-$2.32
EPS diluted
-$2.32
Free cash flow per share
-$1.39
Book value per share
$0.42
Revenue per share
$0.44
TBVPS
$2.82
Balance sheet
Total assets
$224.01M
Total liabilities
$190.92M
Debt
$80.88M
Equity
$33.1M
Working capital
$27.52M
Liquidity
Debt to equity
2.44
Current ratio
1.53
Quick ratio
1.32
Net debt/EBITDA
-0.09
Margins
EBITDA margin
-410.4%
Gross margin
27.1%
Net margin
-484.9%
Operating margin
-460.9%
Efficiency
Return on assets
-63.1%
Return on equity
-241.9%
Return on invested capital
-79.5%
Return on capital employed
-89.9%
Return on sales
-447%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

MGTX stock price

How has the MeiraGTx Holdings stock price performed over time
Intraday
-1.44%
1 week
7.06%
1 month
-24.69%
1 year
10.98%
YTD
-10.34%
QTD
-19.47%

Financial performance

How have MeiraGTx Holdings's revenue and profit performed over time
Revenue
$34.51M
Gross profit
$9.34M
Operating income
-$159.04M
Net income
-$167.33M
Gross margin
27.1%
Net margin
-484.9%
The company's net income has shrunk by 126% YoY and by 13% QoQ
The gross margin has plunged by 73% YoY and by 4.9% from the previous quarter
The operating margin has surged by 66% year-on-year and by 7% since the previous quarter
MeiraGTx Holdings's net margin has increased by 26% YoY but it has decreased by 9% QoQ

Price vs fundamentals

How does MGTX's price correlate with its fundamentals

Growth

What is MeiraGTx Holdings's growth rate over time

Valuation

What is MeiraGTx Holdings stock price valuation
P/E
N/A
P/B
13.01
P/S
12.5
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
13.07
MGTX's EPS has dropped by 98% year-on-year and by 9% since the previous quarter
The stock's price to book (P/B) is 78% more than its last 4 quarters average of 7.3
MGTX's equity has plunged by 73% YoY and by 51% from the previous quarter
MGTX's price to sales (P/S) is 54% lower than its 5-year quarterly average of 27.0 and 40% lower than its last 4 quarters average of 20.8
The revenue has increased by 3.7% QoQ

Efficiency

How efficient is MeiraGTx Holdings business performance
The ROIC has shrunk by 198% YoY and by 21% QoQ
MGTX's return on assets has dropped by 159% year-on-year and by 22% since the previous quarter
MeiraGTx Holdings's return on equity has decreased by 50% QoQ
MGTX's ROS is up by 16% year-on-year but it is down by 11% since the previous quarter

Dividends

What is MGTX's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for MGTX.

Financial health

How did MeiraGTx Holdings financials performed over time
MeiraGTx Holdings's total assets is 17% higher than its total liabilities
The quick ratio has plunged by 52% YoY and by 25% from the previous quarter
The company's current ratio has shrunk by 51% YoY and by 25% QoQ
MeiraGTx Holdings's debt is 144% higher than its equity
The company's debt to equity has surged by 95% QoQ
MGTX's equity has plunged by 73% YoY and by 51% from the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.